Exact Sciences Corporation
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated wit…
Medical - Diagnostics & Research
US, Madison [HQ]
Ratios
15 Sheets · Starting from 2023Margins, Growth Rates In %
| Ratio | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||
| Gross Margin | 99.58 | 99.55 | 99.42 | 100.00 | 100.00 | -140.55 | 37.87 | 54.52 | 70.23 | 74.04 | 75.27 | 76.24 | 74.04 | 72.44 | 73.83 | |
| Profit Margin | -191.03 | -216.24 | -688.81 | -1,264.99 | -1,122.44 | -5,564.40 | -400.14 | -168.26 | -43.01 | -38.54 | -9.59 | -56.90 | -33.71 | -29.91 | -8.17 | |
| Operating Margin | -193.53 | -221.29 | -692.36 | -1,270.32 | -1,128.40 | -5,591.71 | -403.35 | -170.08 | -44.48 | -35.09 | -26.68 | -37.44 | -47.28 | -27.71 | -8.60 | |
|
EPS Growth
|
22.22 | -3.57 | -89.66 | -60.00 | 21.59 | -81.16 | -36.80 | 4.68 | 39.26 | -44.44 | 55.25 | -776.56 | 37.97 | -1.72 | 68.08 | |
| EPS USD | -28.00 | -29.00 | -55.00 | -88.00 | -69.00 | -125.00 | -171.00 | -163.00 | -99.00 | -143.00 | -64.00 | -561.00 | -348.00 | -354.00 | -113.00 | |
| Return on Assets (ROA) | -35.27 | -11.97 | -29.58 | -46.75 | -31.72 | -32.11 | -43.32 | -44.35 | -19.11 | -11.49 | -2.40 | -17.23 | -8.91 | -10.01 | -3.15 | |
| Return on Equity (ROE) | -148.20 | -14.49 | -34.34 | -53.17 | -34.37 | -34.62 | -48.28 | -49.87 | -21.98 | -25.72 | -3.67 | -30.05 | -17.58 | -20.49 | -6.49 | |
| Return on Invested Capital (ROIC) | -124.89 | -14.30 | -34.11 | -51.63 | -33.37 | -33.36 | -45.58 | -46.34 | -22.50 | -11.65 | -2.25 | -12.13 | -10.24 | -10.37 | -3.82 | |
| Solvency | ||||||||||||||||
| Equity Ratio | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Debt/Assets | 3.88 | 1.04 | 1.03 | 1.82 | 1.17 | 0.44 | 1.38 | 1.28 | 0.74 | 45.20 | 27.24 | 35.18 | 35.63 | 39.30 | 39.48 | |
| Debt/Equity | 16.31 | 1.25 | 1.20 | 2.07 | 1.26 | 0.47 | 1.54 | 1.43 | 0.86 | 101.16 | 41.74 | 61.36 | 70.32 | 80.41 | 81.22 | |
| Debt/EBITDA | 227.09 | 656.69 | 122.42 | 22.21 | 24.74 | 56.83 | 22.81 | 26.20 | 61.89 | -331.34 | -353.18 | 5.83 | -276.44 | -459.16 | -14,843.12 | |
|
Debt/Capitalization
|
14.02 | 1.24 | 1.18 | 2.03 | 1.25 | 0.47 | 1.51 | 1.41 | 0.85 | 50.29 | 29.45 | 38.03 | 41.29 | 44.57 | 44.82 | |
| Long-Term Debt/Capitalization | 14.02 | 1.24 | 1.18 | 1.71 | 1.00 | 0.34 | 1.46 | 1.36 | 0.81 | 50.29 | 29.26 | 34.15 | 41.08 | 44.28 | 44.04 | |
| Interest Debt per Share USD | 0.03 | 0.02 | 0.02 | 0.04 | 0.03 | 0.02 | 0.05 | 0.05 | 0.04 | 5.94 | 7.75 | 12.10 | 14.01 | 13.99 | 14.32 | |
| Debt Growth | - - | - - | - - | 71.10 | -20.51 | -26.47 | 385.20 | -4.51 | -7.86 | 16,035.44 | 37.38 | 54.73 | 61.35 | 3.58 | 4.41 | |
| Liquidity | ||||||||||||||||
| Current Ratio | 382.49 | 1,336.42 | 1,183.34 | 949.05 | 1,747.39 | 1,664.73 | 1,220.41 | 1,086.84 | 715.19 | 899.09 | 235.51 | 381.80 | 275.83 | 237.98 | 232.05 | |
| Quick Ratio | 375.03 | 1,332.98 | 1,170.38 | 943.88 | 1,719.03 | 1,621.67 | 1,166.83 | 1,041.40 | 662.22 | 855.42 | 192.11 | 360.02 | 241.19 | 191.42 | 190.65 | |
| Cash Ratio | 337.97 | 1,100.20 | 448.55 | 116.50 | 165.78 | 331.78 | 153.93 | 159.39 | 113.75 | 117.45 | 74.95 | 258.97 | 61.01 | 58.75 | 117.62 | |
| Operating Cash Flow Ratio | -100 | -100 | -300 | -300 | -500 | -400 | -500 | -400 | -100 | - - | - - | - - | - - | - - | - - | |
| Turnover | ||||||||||||||||
| Inventory Turnover | - - | - - | - - | - - | - - | 107.67 | 366.95 | 661.42 | 304.28 | 301.37 | 351.11 | 384.03 | 436.94 | 485.71 | 513.20 | |
| Receivables Turnover | - - | - - | - - | - - | - - | 130.67 | 799.45 | 1,165.56 | 1,006.81 | 1,027.29 | 670.63 | 639.57 | 815.66 | 1,318.81 | 1,227.64 | |
| Payables Turnover | 12.90 | 2.34 | 3.14 | - - | - - | 163.39 | 740.66 | 6,365.49 | 490.83 | 419.25 | 834.39 | 992.25 | 676.34 | 766.72 | 830.04 | |
|
Asset Turnover
|
18.46 | 5.54 | 4.29 | 3.70 | 2.83 | 0.58 | 10.83 | 26.36 | 44.44 | 29.82 | 25.00 | 30.28 | 26.43 | 33.47 | 38.63 | |
| Fixed Turnover | 1,038.86 | 625.76 | 162.74 | 121.70 | 37.10 | 9.01 | 115.66 | 260.54 | 332.54 | 185.30 | 150.63 | 258.64 | 234.21 | 244.70 | 296.86 | |
| Coverage | ||||||||||||||||
| Interest Coverage | - - | - - | -137,252.38 | -128,395.12 | -67,769.57 | -197,135.29 | -2,651,133.33 | -79,350.23 | -57,432.04 | -433.47 | -379.52 | -581.72 | -4,490.31 | -2,941.54 | -880.44 | |
| Asset Coverage | 1,900 | 8,900 | 8,800 | 5,900 | 10,200 | 29,400 | 6,900 | 7,400 | 11,900 | 100 | 200 | 200 | 100 | 100 | 100 | |
| Cash Flow Coverage (CFGR) | -1,264.00 | -1,347.80 | -2,782.40 | -2,160.23 | -2,296.61 | -5,949.41 | -2,670.73 | -2,705.76 | -1,611.41 | -10.06 | -12.04 | 7.88 | -4.29 | -9.14 | 6.11 | |
| EBITDA Coverage | - - | - - | -135,200 | -127,700 | -67,300 | -197,100 | -2,651,100 | -79,300 | -57,400 | -400 | -300 | -400 | -3,900 | -2,400 | - - | |
| Dividend Coverage | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Time Interest Earned (TIE) | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Market Prospects | ||||||||||||||||
| Dividend Yield | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Earnings Yield | -8.18 | -4.78 | -6.73 | -8.32 | -5.87 | -4.54 | -18.56 | -12.23 | -1.88 | -2.27 | -0.69 | -4.24 | -4.47 | -7.14 | -1.53 | |
|
Price/Earnings (P/E)
|
-1,223.03 | -2,093.47 | -1,487.00 | -1,201.62 | -1,704.95 | -2,200.51 | -538.90 | -817.65 | -5,313.11 | -4,402.69 | -14,451.97 | -2,359.85 | -2,239.00 | -1,400.33 | -6,528.10 | |
| Price/Earnings Growth (PEG) | 55.04 | -586.17 | -16.59 | -20.03 | 78.97 | -27.11 | -14.64 | 174.77 | 135.32 | -99.06 | 261.60 | -3.04 | 58.97 | -812.19 | 95.89 | |
|
Price/Book (P/B)
|
1,812.51 | 303.33 | 510.69 | 638.88 | 586.07 | 761.83 | 260.18 | 407.76 | 1,167.91 | 1,132.44 | 530.52 | 709.20 | 393.67 | 286.91 | 423.71 | |
| Price/Tangible Book (P/TB) | 1,812.51 | 303.33 | 510.69 | 638.88 | 586.07 | 761.83 | 260.18 | 407.76 | 1,167.91 | 1,132.44 | 530.52 | 709.20 | 393.67 | 286.91 | 423.71 | |
| Price/Sales (P/S) | 2,336.31 | 4,526.96 | 10,242.55 | 15,200.38 | 19,137.13 | 122,445.28 | 2,156.37 | 1,375.78 | 2,285.07 | 1,696.79 | 1,385.23 | 1,342.65 | 754.69 | 418.90 | 533.13 | |
|
Price/Cash Flow (P/CF)
|
-879.44 | -1,794.93 | -1,532.48 | -1,426.57 | -2,018.18 | -2,720.94 | -634.55 | -1,051.16 | -8,474.20 | -11,123.35 | -10,554.43 | 14,671.64 | -13,044.34 | -3,905.52 | 8,536.47 | |
| Price/Free CF (P/FCF) | -848.43 | -1,715.26 | -1,424.22 | -1,404.91 | -1,632.55 | -2,355.90 | -545.13 | -943.43 | -4,311.77 | -3,505.18 | -4,232.27 | 27,761.18 | -5,603.32 | -1,993.31 | 41,739.65 | |
| Price/Operating CF (P/OCF) | -879.44 | -1,794.93 | -1,532.48 | -1,426.57 | -2,018.18 | -2,720.94 | -634.55 | -1,051.16 | -8,474.20 | -11,123.35 | -10,554.43 | 14,671.64 | -13,044.34 | -3,905.52 | 8,536.47 |